| Primary |
| Prostate Cancer Metastatic |
29.3% |
| Prostate Cancer |
26.8% |
| Prophylaxis |
23.6% |
| Drug Therapy |
6.5% |
| Premedication |
3.3% |
| Hypertension |
2.2% |
| Nausea |
1.3% |
| Drug Use For Unknown Indication |
1.2% |
| Pain |
1.2% |
| Diabetes Mellitus |
0.6% |
| Abdominal Pain |
0.5% |
| Breast Cancer |
0.5% |
| Constipation |
0.5% |
| Malignant Solid Tumor |
0.5% |
| Analgesic Therapy |
0.4% |
| Atrial Fibrillation |
0.4% |
| Carcinoma Of The Prostate Metastatic |
0.4% |
| Cardiovascular Event Prophylaxis |
0.4% |
| Colon Cancer |
0.4% |
| Deep Vein Thrombosis |
0.4% |
|
| Pulmonary Embolism |
15.9% |
| Death |
11.8% |
| Syncope |
6.5% |
| Neutropenia |
5.3% |
| Sepsis |
4.7% |
| Thrombocytopenia |
4.7% |
| Disseminated Intravascular Coagulation |
4.1% |
| Pancytopenia |
4.1% |
| Pneumonia |
4.1% |
| Small Intestinal Obstruction |
4.1% |
| Sudden Death |
4.1% |
| Diarrhoea |
3.5% |
| Gastric Ulcer |
3.5% |
| Gastrointestinal Haemorrhage |
3.5% |
| Neutropenic Sepsis |
3.5% |
| Pulmonary Oedema |
3.5% |
| Pyrexia |
3.5% |
| Vomiting |
3.5% |
| Cholecystitis |
2.9% |
| Duodenal Ulcer |
2.9% |
|
| Secondary |
| Prostate Cancer Metastatic |
30.6% |
| Prophylaxis |
26.1% |
| Prostate Cancer |
18.5% |
| Drug Therapy |
7.3% |
| Premedication |
2.6% |
| Hypertension |
2.0% |
| Product Used For Unknown Indication |
1.9% |
| Drug Use For Unknown Indication |
1.4% |
| Diarrhoea |
1.1% |
| Malignant Solid Tumor |
1.1% |
| Non-small Cell Lung Cancer |
1.1% |
| Nutritional Supplementation |
1.1% |
| Gastritis |
1.0% |
| Deep Vein Thrombosis |
0.8% |
| Atrial Fibrillation |
0.7% |
| Hormone-refractory Prostate Cancer |
0.7% |
| Dyspnoea |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Cardiovascular Event Prophylaxis |
0.5% |
| Osteoporosis Prophylaxis |
0.5% |
|
| Pulmonary Embolism |
20.3% |
| Death |
9.0% |
| Syncope |
9.0% |
| Pyrexia |
4.5% |
| Sepsis |
4.5% |
| Cholecystitis |
3.8% |
| Cystitis Radiation |
3.8% |
| Febrile Neutropenia |
3.8% |
| Gastrointestinal Haemorrhage |
3.8% |
| Haemorrhagic Anaemia |
3.8% |
| Neutropenia |
3.8% |
| Pancytopenia |
3.8% |
| Small Intestinal Obstruction |
3.8% |
| Thrombocytopenia |
3.8% |
| Urinary Retention |
3.8% |
| Acute Myocardial Infarction |
3.0% |
| Cardiac Failure |
3.0% |
| Cataract |
3.0% |
| Chemical Cystitis |
3.0% |
| Diarrhoea |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.2% |
| Metastases To Bone |
15.4% |
| Prostate Cancer |
15.4% |
| Pain Management |
6.0% |
| Prostate Cancer Metastatic |
6.0% |
| Nausea |
5.4% |
| Anxiety |
4.7% |
| Sleep Disorder |
4.0% |
| Vomiting |
4.0% |
| Depression |
2.7% |
| Convulsion |
1.3% |
| Diarrhoea |
1.3% |
| Hypertension |
1.3% |
| Hypocalcaemia |
1.3% |
| Insomnia |
1.3% |
| Osteoporosis |
1.3% |
| Pain |
1.3% |
| Prophylaxis |
1.3% |
| Arthralgia |
0.7% |
| Blood Cholesterol Increased |
0.7% |
|
| Drug Hypersensitivity |
8.0% |
| Osteonecrosis Of Jaw |
8.0% |
| Surgery |
8.0% |
| Trousseau's Sign |
8.0% |
| Weight Decreased |
8.0% |
| Bone Pain |
4.0% |
| Cellulitis |
4.0% |
| Chest Pain |
4.0% |
| Dyspnoea |
4.0% |
| Fall |
4.0% |
| Haemorrhage |
4.0% |
| Hospice Care |
4.0% |
| Neutropenia |
4.0% |
| Pain |
4.0% |
| Pneumonia |
4.0% |
| Polyneuropathy |
4.0% |
| Pyramidal Tract Syndrome |
4.0% |
| Pyrexia |
4.0% |
| Septic Shock |
4.0% |
| Tooth Disorder |
4.0% |
|
